Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > IIRoc should investigate SZLS and Halt it until next year
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(84)
•••
Comment by Jonnyboy85on Oct 27, 2020 10:26pm
115 Views
Post# 31793635

RE:RE:RE:RE:RE:RE:RE:RE:IIRoc should investigate SZLS and Halt it until next year

RE:RE:RE:RE:RE:RE:RE:RE:IIRoc should investigate SZLS and Halt it until next year And last of the night but not least, my favourite quote of Olteanu/DrChristian/Ompong/Euro007. bwwwwaaahahahahahahahahahahahahahahah  


[quote=Olteanu007]From a Pumper to a Basher and the other way around. What ever fits your agenda : SAGDollar (786) Post# 30315013 Sold some of my position today for EDT Goin to the moon this week with EDT currently at 70 cents just got in. Its forcasted for 2 bucks. And is breaking out RIGHT NOW. Il be back at SZLS before Q3. Happy green hump day. See it here: https://stockhouse.com/companies/bullboard?symbol=t.szls&postid=30315013
SAGDollar wrote: Better get your lawyers after Echelon there oletenau. Betcha Jimmy paid them off to fund szls with over 4M. I love that we can shut these clowns down with hard facts and not just hit the Iggy or report button.


[/quote]

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested